Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Rivaroxaban in Pediatric Patients With Deep Venous Thrombosis

NCT07618988 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07618988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07618988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Rivaroxaban in Pediatric Patients With Deep Venous Thrombosis
Lead sponsor
Ain Shams University
Phase
Phase 4
Overall status
Completed
Start date
August 3, 2024
Completion date
May 1, 2026
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric venous thromboembolism